Back

Applicability of VICTORION-1 PREVENT Criteria to the US Population

2 September 2024 (11:35 - 11:45)
Organised by: Logo
Congress Presentation Part of: Epidemiology of cardiovascular risk and disease Epidemiology ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Rahul Aggarwal

Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)

5 More presentations in this session

Presentation thumbnail
Cardiovascular disease burden and risk factor management in cancer survivors: insights from a large-scale East London cohort
Doctor L. Szabo (Budapest, HU)
Abstract Slides Video
Presentation thumbnail
Heterogeneous associations of traditional atherosclerotic risk factors and long-term events in different arterial territories: the EPIC Norfolk prospective population cohort
Miss M. van den Bogaart (Amsterdam, NL)
Abstract Slides Video
Presentation thumbnail
LDL-cholesterol and CRP as predictors of CV morbidity and mortality - a comprehensive analysis of data from the UK Biobank
Slides
Presentation thumbnail
Independent and joint associations of urinary potassium excretion with cardiovascular death: a national population-based cohort study
Ms C. Lin (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
The projected global burden of modifiable risk factors on cardiovascular disease from 2025 to 2100
Mr B. Chong (Singapore, SG)
Abstract Slides Video

Access the full session

Session thumbnail
Epidemiology of cardiovascular risk and disease
Video

The Event

Event poster

ESC Congress 2024

2 September 2024 11:35 CET
You may be interested in
thumbnail
Congress Session
Epidemiology of cardiovascular risk and disease
thumbnail
Congress Presentation
Associations of VICTORION-1 PREVENT eligibility with subclinical cardiovascular and inflammatory damage in a european population-based cohort
thumbnail
Congress Session
The best publications on preventive cardiology from the European Heart Journal (EHJ) and the European Journal of Preventive Cardiology (EJPC)

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources